Related Experiment Video
Updated: Jun 12, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
[Renal abnormalities in HIV infected patients]
María Marta Pernasetti1, Carlos Chiurchiu, Jorge de la Fuente
1Servicio de Nefrología y Carrera de Posgrado, Universidad Católica de Córdoba, Argentina.
Medicina
|June 10, 2010
Summary
Renal abnormalities are common in asymptomatic HIV-infected patients, even without advanced disease. Routine kidney evaluations are recommended for early detection and management of these complications.
Area of Science:
- Nephrology
- Infectious Diseases
- HIV Medicine
Context:
- Renal complications are known in advanced HIV stages.
- Prevalence of kidney disease in asymptomatic HIV patients is understudied.
- This study investigated renal abnormalities in asymptomatic HIV(+) individuals.
Purpose:
- To determine the prevalence of renal abnormalities in asymptomatic HIV-infected patients.
- To identify potential risk factors and types of kidney lesions in this population.
Summary:
- A cross-sectional study of 52 asymptomatic HIV(+) patients revealed significant renal abnormalities in 30.7%.
- Common findings included albuminuria, hematuria, hypercalciuria, and crystalluria.
- 41% had chronic kidney disease (stages 1-3); tubulointerstitial nephritis and IgA nephropathy were noted on biopsy. No HIV-associated nephropathy was detected.
Impact:
- The high prevalence of renal lesions underscores the need for routine renal evaluation in asymptomatic HIV-infected patients.
- Early detection of kidney disease can lead to timely intervention and improved patient outcomes.
- Findings suggest age, not necessarily HIV disease stage, may be linked to renal abnormalities.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...